首页 | 本学科首页   官方微博 | 高级检索  
     

华蟾毒精和羟基华蟾毒精的人肠内细菌代谢研究
引用本文:杨秀伟,邢增涛,崔景荣,范玉林,赵锐,李向高. 华蟾毒精和羟基华蟾毒精的人肠内细菌代谢研究[J]. 北京大学学报(医学版), 2001, 33(3): 199-204
作者姓名:杨秀伟  邢增涛  崔景荣  范玉林  赵锐  李向高
作者单位:^AThe State Key Laboratory of Natural and Biomimetic Drugs, Peking Universi ty School of Pharmaceu tical Sciences ,^BPeking Universi ty School of Pharmaceu tical Sciences^C471812^D1%^A吉林农业大学中药材学院^BChinese Medicina l Materials College of Jilin Agricultural University^C883539^D2
基金项目:教育部高校骨干教师资助计划;1995;
摘    要:目的:研究人肠内细菌对蟾酥中主要成分华蟾毒精和羟基华蟾毒精的代谢。方法:采用体外人肠内细菌粗酶与华蟾毒精和羟基华蟾毒精温孵法;根据波谱学和化学数据鉴定代谢产物的结构;根据原形化合物和代谢产物的体外抑制人癌细胞系(HCT-8、KB、BGC、BIU 和HeLa )的生长评价其抗肿瘤活性。结果:华蟾毒精可由人肠内细菌代谢产生去乙酰基华蟾毒精;羟基华蟾毒精可由人肠内细菌代谢产生去乙酰基羟基华蟾毒精;原形化合物具有强抑制人癌细胞生长的活性,而其代谢产物无活性。结论:华蟾毒精和羟基华蟾毒精由肠内细菌代谢而失活。

关 键 词:华蟾毒精/代谢  羟基华蟾毒精  肠杆菌属  肠球菌属  抗肿瘤药/代谢  
文章编号:1671-167X(2001)03-0199-06
修稿时间:2001-03-13

Studies on the metabolism of cinobufagin and cinobufotalin by human intestinal bacteria
YANG Xiu-Wei,XING Zeng-Tao,CUI Jing-rong,FAN Yu-Lin,Z HAO Rui,LI Xiang-gao. Studies on the metabolism of cinobufagin and cinobufotalin by human intestinal bacteria[J]. Journal of Peking University. Health sciences, 2001, 33(3): 199-204
Authors:YANG Xiu-Wei  XING Zeng-Tao  CUI Jing-rong  FAN Yu-Lin  Z HAO Rui  LI Xiang-gao
Affiliation:YANG Xiu Wei 1,XING Zeng Tao 2,CUI Jing Rong 1,FAN Yu Lin 2,ZHAO Rui 2,LI Xiang Gao 2
Abstract:To study metabolism of cinobufagin and cinobufotalin, which are main constituents in Venenum Bufonis by human intestinal bacteria. Methods: The cinobufagin and cinobufotalin were incubated with crude enzymes of human intestinal bacteria in vitro . The structures of metabolites were determined on the basis of spectroscopic and chemical evidence. The inhibitory effects of cinobufagin, cinobufotalin and their metabolites on the growth of human tumorcell lines (HCT 8, KB, BGC, BIU and HeLa) were evaluated by bioassay in vitro . Results: Cinobufagin and cinobufotalin were converted to deacetylcinobufagin and deacetylcinobufotalin by human intestinal bacteria, respectively. The primary compounds showed potentially inhibitory effects on several lines of human tumor cells, but the metabolites showed no effect on them in vitro .Conclusion: These results suggest that cinobufagin and cinobufotalin are converted to deacetylcinobufagin and deacetylcinobufotalin and thereby deactivated by human intestinal bacteria. The metabolites do not play an important role in the antitumor action of cinobufagin and cinobufotalin.
Keywords:Cinobufagin/metab  Cinobufotalin  Enterobacter  Enterococcus  Antineoplastic agents/metab
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《北京大学学报(医学版)》浏览原始摘要信息
点击此处可从《北京大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号